Page last updated: 2024-10-17

choline and Adenopathy

choline has been researched along with Adenopathy in 3 studies

Research Excerpts

ExcerptRelevanceReference
" 18F-Choline PET/MRI revealed incidental bilateral axillary lymphadenopathy with mild-moderate increased 18F-choline uptake."8.31Bilateral Lymphadenopathy After COVID Vaccine in 18F-Choline PET/MRI Performed for Hyperparathyroidism. ( Aghazada, F; Asa, S; Kibar, A; Sonmezoglu, K; Uslu Besli, RL, 2023)
" 18F-Choline PET/MRI revealed incidental bilateral axillary lymphadenopathy with mild-moderate increased 18F-choline uptake."4.31Bilateral Lymphadenopathy After COVID Vaccine in 18F-Choline PET/MRI Performed for Hyperparathyroidism. ( Aghazada, F; Asa, S; Kibar, A; Sonmezoglu, K; Uslu Besli, RL, 2023)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's3 (100.00)2.80

Authors

AuthorsStudies
Albano, D1
Volpi, G1
Dondi, F1
Giubbini, R1
Bertagna, F1
Kibar, A1
Aghazada, F1
Asa, S1
Uslu Besli, RL1
Sonmezoglu, K1
Nawwar, AA1
Searle, J1
Singh, R1
Lyburn, ID1

Other Studies

3 other studies available for choline and Adenopathy

ArticleYear
COVID-19 Vaccination Manifesting as Unilateral Lymphadenopathies Detected by 18F-Choline PET/CT.
    Clinical nuclear medicine, 2022, Feb-01, Volume: 47, Issue:2

    Topics: Aged; Choline; COVID-19; COVID-19 Vaccines; Humans; Lymphadenopathy; Male; Neoplasm Recurrence, Loca

2022
Bilateral Lymphadenopathy After COVID Vaccine in 18F-Choline PET/MRI Performed for Hyperparathyroidism.
    Clinical nuclear medicine, 2023, Mar-01, Volume: 48, Issue:3

    Topics: Choline; COVID-19; COVID-19 Vaccines; Female; Humans; Hyperparathyroidism; Lymphadenopathy; Magnetic

2023
Oxford-AstraZeneca COVID-19 vaccination induced lymphadenopathy on [18F]Choline PET/CT-not only an FDG finding.
    European journal of nuclear medicine and molecular imaging, 2021, Volume: 48, Issue:8

    Topics: Choline; COVID-19; COVID-19 Vaccines; Fluorodeoxyglucose F18; Humans; Lymphadenopathy; Positron Emis

2021